Immutep (IMMP)

Immutep (IMMP) Stock Price & Analysis


IMMP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.47 - $3.90
Previous Close$1.92
Average Volume (3M)160.73K
Market Cap
Enterprise Value$172.68M
Total Cash (Recent Filing)AU$68.38M
Total Debt (Recent Filing)AU$952.66K
Price to Earnings (P/E)-6.4
Feb 22, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding86,623,982
10 Day Avg. Volume90,136
30 Day Avg. Volume160,734
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)2.53
Price to Sales (P/S)24.61
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside264.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Immutep’s price range in the past 12 months?
Immutep lowest stock price was $1.47 and its highest was $3.90 in the past 12 months.
    What is Immutep’s market cap?
    Currently, no data Available
    When is Immutep’s upcoming earnings report date?
    Immutep’s upcoming earnings report date is Feb 22, 2024 which is in 147 days.
      How were Immutep’s earnings last quarter?
      Immutep released its earnings results on Aug 29, 2023. The company reported -$0.136 earnings per share for the quarter, beating the consensus estimate of -$0.153 by $0.017.
        Is Immutep overvalued?
        According to Wall Street analysts Immutep’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Immutep pay dividends?
          Immutep does not currently pay dividends.
          What is Immutep’s EPS estimate?
          Immutep’s EPS estimate is -$0.18.
            How many shares outstanding does Immutep have?
            Immutep has 118,730,620 shares outstanding.
              What happened to Immutep’s price movement after its last earnings report?
              Immutep reported an EPS of -$0.136 in its last earnings report, beating expectations of -$0.153. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Immutep?
                Among the largest hedge funds holding Immutep’s share is Oracle Investment Management Inc. It holds Immutep’s shares valued at 2M.


                  Immutep Stock Smart Score

                  The Immutep stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.


                  Top 5 ETFs holding IMMP

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold IMMP. The ETFs are listed according to market value of IMMP within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  SELLAS Life Sciences Group

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis